An earlier study of the SBA immune environment reported a high expression of PD-1 in peritumoral and intratumoral lymphocytes (83%) and PD-L1 in both tumour cells (17%) and tumour-infiltrating lymphocytes (43%) [28]. Here, PDCD1 is linked to neoplasm.